Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a multicenter, randomized, open label, phase III study.
Epistemonikos ID: e508f573e5099324ad2ae9bdaceffeb2d14c3d51
First added on: May 08, 2024